ArticleCureus2025
Tuberculosis Epidemiology and the Impact of the COVID-19 Pandemic on Tuberculosis Control in Tétouan, Morocco (2015-2022): A Retrospective Descriptive and Analytical Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spatiotemporal patterns of tuberculosis in urban slums and urban-rural transition zones: evidence from Tétouan, Morocco, 2019-2023.PLOS global public health · 2026Article
- [A complex diagnostic triad mimicking macrophage activation syndrome: chronic lymphocytic leukemia and tuberculosis (a case report)].The Pan African medical journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTuberculosis (TB) is a major public health problem in Morocco, specifically in the Tangier-Tetouan-Al-Hoceima region, which includes the city of Tetouan. Although the improvement in the epidemiological situation in Tetouan over the past two decades, this remains insufficient to achieve the ultimate goal of eradicating tuberculosis. The present study describes and analyzes tuberculosis's epidemiological status in Tetouan between 2015 and 2022 to understand the evolution of infection, especially before and during the COVID-19 pandemic.
methodsA retrospective study was conducted on tuberculosis patients registered in Tetouan from January 2015 to December 2022. Data on demographic characteristics and clinical tuberculosis presentations were analyzed using IBM SPSS Statistics software (IBM Corp., Armonk, NY, USA), with significance determined at a p-value < 0.05.
resultsA total of 6,397 TB cases were reported between 2015 and 2022, with an average incidence rate of 127.33 per 100,000 inhabitants. Males were more frequently affected, with a sex ratio of 1.64. The majority of cases occurred in young adults (15-34 years), with an average patient age of 39.69 years. New cases accounted for 5,751 (89.90%) of the total. Intra-pulmonary tuberculosis was the most common form, representing 3,612 cases (56.50%), of which 3,038 (88.39%) were bacteriologically confirmed. Among extra-pulmonary tuberculosis cases, pleural tuberculosis was the most prevalent, affecting 1,220 patients (43.79%). The cure rate was 5,236 (89.87%), while mortality remained below 3% (159 cases). The treatment dropout rate was 4.28% (249 cases). The COVID-19 pandemic led to a significant decline in TB notifications and an increase in the number of patients lost to follow-up.
conclusionDespite the favorable epidemiological evolution of the disease in Tetouan, many efforts are essential for more case detection and to overcome the impact of the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.